Peptide Encyclopedia / Chonluten
EncyclopediaChonluten is a short Khavinson-group peptide bioregulator marketed for the lungs and airways, said to support respiratory epithelial function. That mechanism is largely theoretical, the evidence is anecdotal and Russian-origin only, and the US has no marketing authorization for it. Educational, not medical advice.
| Category | Immune |
| Regulatory status | Not FDA-approved in the US (research chemical status). |
A short peptide bioregulator (Khavinson group) marketed as tissue-specific for the bronchopulmonary system; reported to support respiratory epithelial function. Mechanism is not characterized in peer-reviewed Western literature and is largely theoretical.
Not established; no reliable human pharmacokinetic data.
Not FDA-approved in the US (research chemical status). Associated with Russian bioregulator products; no US marketing authorization and minimal regulatory documentation.
Essentially no published independent human safety data; sterility/purity risks apply to unregulated product.
Anecdotal and limited Russian-origin reports only; no independent Western trials. Evidence is very scarce.
PepWise is an informational and educational tracking tool, not medical advice and not a medical device. Chonluten may be experimental, restricted, or prescription-only; many research peptides are not FDA-approved. Consult a licensed healthcare provider before starting, changing, or stopping any protocol. Operated by STC Consulting, Inc.
